JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Home・Aktien・Pulmatrix Inc

Pulmatrix Inc

Geschlossen

1.27 3.25

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.24

Max

1.27

Schlüsselkennzahlen
By Trading Economics
Einkommen	-51K -928K
EPS	-0.254
Angestellte	2
EBITDA	-51K -928K

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-6.5M 4.9M
Vorheriger Eröffnungskurs	-1.98
Vorheriger Schlusskurs	1.27

Pulmatrix Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Mai 2026, 22:17 UTC

Ergebnisse

Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%

4. Mai 2026, 23:47 UTC

Ergebnisse

Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB

4. Mai 2026, 23:45 UTC

Ergebnisse

Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB

4. Mai 2026, 23:45 UTC

Ergebnisse

Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB

4. Mai 2026, 23:40 UTC

Market Talk

Gold Steady Amid Likely Technical Recovery -- Market Talk

4. Mai 2026, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Jim Beyer To Be Chief Executive of Combined Company

4. Mai 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company

4. Mai 2026, 22:42 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits

4. Mai 2026, 22:42 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation

4. Mai 2026, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Combined Company to Have Annual Production of More Than 700,000 Oz

4. Mai 2026, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Pro Forma Market Capitalization About A$10.7 Billion

4. Mai 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Shareholders to Own About 51% of Combined Company

4. Mai 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Board Unanimously Endorsed, Supported Deal

4. Mai 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Deal Unanimously Recommended by Vault Board

4. Mai 2026, 22:39 UTC

Akquisitionen, Fusionen, Übernahmen

Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held

4. Mai 2026, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Regis Resources to Acquire All Ordinary Shares in Vault

4. Mai 2026, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Regis Resources, Vault Minerals Agree to Merger of Equals

4. Mai 2026, 22:37 UTC

Ergebnisse

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update

4. Mai 2026, 22:26 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update

4. Mai 2026, 22:02 UTC

Ergebnisse

Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%

4. Mai 2026, 22:00 UTC

Market Talk

BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk

4. Mai 2026, 21:52 UTC

Ergebnisse

Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU

4. Mai 2026, 21:50 UTC

Ergebnisse

Westpac: Some Sectors More Affected Than Others>WBC.AU

4. Mai 2026, 21:50 UTC

Ergebnisse

Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU

4. Mai 2026, 21:49 UTC

Ergebnisse

Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU

4. Mai 2026, 21:44 UTC

Ergebnisse

Westpac 1H Australia Lending Up 8% on Year>WBC.AU

4. Mai 2026, 21:44 UTC

Ergebnisse

Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU

4. Mai 2026, 21:43 UTC

Ergebnisse

Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU

4. Mai 2026, 21:41 UTC

Ergebnisse

Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU

4. Mai 2026, 21:40 UTC

Ergebnisse

Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU

Peer-Vergleich

Kursveränderung

Pulmatrix Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pulmatrix Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.